Filed: 8/14/2026ACC: 0001420506-26-001734
📋 What this filing means
PARKMAN HEALTHCARE PARTNERS LLC filed this quarterly 13F‑HR report disclosing 77 equity positions with a total reported market value of $976.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
77
Positions
$976.83M
Total AUM (reported)
33.83M
Total Shares
Allocation by class
COM$793.63M81.2%
COM NEW$90.89M9.3%
SHS$27.39M2.8%
SPONSORED ADS$26.07M2.7%
COM SHS$12.98M1.3%
COM STK CL A$9.37M1.0%
COM PAR $0.001$7.98M0.8%
Portfolio Concentration
Top 3$126.68M13.0%
4–10$200.44M20.5%
11–25$293.76M30.1%
Rest$355.94M36.4%
Top 3 weight
13.0%
Top 10 weight
33.5%
Voting Authority Distribution
Total shares with voting rights: 33.83M
Sole
Full voting authority
33.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole77
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings77
Rows:
MBX BIOSCIENCES INC
SOLEShares800.17K
TypeSH
Market value$44.17M
4.52%
Sole
800.17K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares35K
TypeSH
Market value$41.98M
4.30%
Sole
35K
Shared
0.00
None
0.00
CVS HEALTH CORP
SOLEShares391.79K
TypeSH
Market value$40.53M
4.15%
Sole
391.79K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares534.77K
TypeSH
Market value$36.02M
3.69%
Sole
534.77K
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares435.69K
TypeSH
Market value$35.54M
3.64%
Sole
435.69K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares919.27K
TypeSH
Market value$28.34M
2.90%
Sole
919.27K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares485.66K
TypeSH
Market value$26.07M
2.67%
Sole
485.66K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$25.31M
2.59%
Sole
1.38M
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares669.05K
TypeSH
Market value$24.83M
2.54%
Sole
669.05K
Shared
0.00
None
0.00
INHIBRX BIOSCIENCES INC
SOLEShares256.95K
TypeSH
Market value$24.35M
2.49%
Sole
256.95K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares397.38K
TypeSH
Market value$23.99M
2.46%
Sole
397.38K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares577.04K
TypeSH
Market value$23.44M
2.40%
Sole
577.04K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares55.92K
TypeSH
Market value$23.24M
2.38%
Sole
55.92K
Shared
0.00
None
0.00
STRYKER CORPORATION
SOLEShares67.97K
TypeSH
Market value$21.40M
2.19%
Sole
67.97K
Shared
0.00
None
0.00
IQVIA HLDGS INC
SOLEShares105.81K
TypeSH
Market value$20.44M
2.09%
Sole
105.81K
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares232.56K
TypeSH
Market value$20.02M
2.05%
Sole
232.56K
Shared
0.00
None
0.00
INSULET CORP
SOLEShares131.38K
TypeSH
Market value$20.00M
2.05%
Sole
131.38K
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares721.18K
TypeSH
Market value$19.82M
2.03%
Sole
721.18K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares877.26K
TypeSH
Market value$19.18M
1.96%
Sole
877.26K
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares1.29M
TypeSH
Market value$18.42M
1.89%
Sole
1.29M
Shared
0.00
None
0.00
TENET HEALTHCARE CORP
SOLEShares97.28K
TypeSH
Market value$18.20M
1.86%
Sole
97.28K
Shared
0.00
None
0.00
LIVANOVA PLC
SOLEShares210.53K
TypeSH
Market value$17.31M
1.77%
Sole
210.53K
Shared
0.00
None
0.00
ANI PHARMACEUTICALS INC
SOLEShares202.91K
TypeSH
Market value$16.80M
1.72%
Sole
202.91K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.62M
TypeSH
Market value$16.24M
1.66%
Sole
1.62M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares50.67K
TypeSH
Market value$15.25M
1.56%
Sole
50.67K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MBX BIOSCIENCES INCSOLE | COM | 800.17K | SH | $44.17M 4.52% | 800.17K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 35K | SH | $41.98M 4.30% | 35K | 0.00 | 0.00 |
CVS HEALTH CORPSOLE | COM | 391.79K | SH | $40.53M 4.15% | 391.79K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 534.77K | SH | $36.02M 3.69% | 534.77K | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | COM | 435.69K | SH | $35.54M 3.64% | 435.69K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 919.27K | SH | $28.34M 2.90% | 919.27K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 485.66K | SH | $26.07M 2.67% | 485.66K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $25.31M 2.59% | 1.38M | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 669.05K | SH | $24.83M 2.54% | 669.05K | 0.00 | 0.00 |
INHIBRX BIOSCIENCES INCSOLE | COM | 256.95K | SH | $24.35M 2.49% | 256.95K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 397.38K | SH | $23.99M 2.46% | 397.38K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 577.04K | SH | $23.44M 2.40% | 577.04K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 55.92K | SH | $23.24M 2.38% | 55.92K | 0.00 | 0.00 |
STRYKER CORPORATIONSOLE | COM | 67.97K | SH | $21.40M 2.19% | 67.97K | 0.00 | 0.00 |
IQVIA HLDGS INCSOLE | COM | 105.81K | SH | $20.44M 2.09% | 105.81K | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 232.56K | SH | $20.02M 2.05% | 232.56K | 0.00 | 0.00 |
INSULET CORPSOLE | COM | 131.38K | SH | $20.00M 2.05% | 131.38K | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 721.18K | SH | $19.82M 2.03% | 721.18K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 877.26K | SH | $19.18M 1.96% | 877.26K | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 1.29M | SH | $18.42M 1.89% | 1.29M | 0.00 | 0.00 |
TENET HEALTHCARE CORPSOLE | COM NEW | 97.28K | SH | $18.20M 1.86% | 97.28K | 0.00 | 0.00 |
LIVANOVA PLCSOLE | SHS | 210.53K | SH | $17.31M 1.77% | 210.53K | 0.00 | 0.00 |
ANI PHARMACEUTICALS INCSOLE | COM | 202.91K | SH | $16.80M 1.72% | 202.91K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.62M | SH | $16.24M 1.66% | 1.62M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 50.67K | SH | $15.25M 1.56% | 50.67K | 0.00 | 0.00 |
Page 1 of 4